LP
GOSS icon

LMR Partners’s Gossamer Bio GOSS Stock Holding History

LMR Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-115,649
Closed -$127K – 1486
2025
Q1 		$127K Buy
+115,649
New +$134K ﹤0.01% 1119
2024
Q3 		– Sell
-58,445
Closed -$52.7K – 1380
2024
Q2 		$52.7K Hold
58,445
– – ﹤0.01% 922
2024
Q1 		$69K Buy
+58,445
New +$64.3K ﹤0.01% 960

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

LMR Partners's GOSS Position: Q2 2025 in Review

LMR Partners sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 115,649 shares — an estimated $127K sold.

LMR Partners first reported a position in GOSS in Q1 2024 and held it in 3 quarters. The position peaked at $127K in Q1 2025. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • LMR Partners reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • LMR Partners sold 115,649 Gossamer Bio shares in Q2 2025, an estimated $127K.
  • LMR Partners first reported a position in Gossamer Bio in Q1 2024 and held it in 3 quarters.
  • LMR Partners's Gossamer Bio position peaked at $127K in Q1 2025.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.